Influenza

Pre-clinical and clinical studies are identifying new preventive vaccines and antiviral therapies
essential for effectively managing influenza from the population level to the individual patient. Ongoing research is refining demographically targeted
approaches to influenza to optimize antibody response, including high-dose vaccines
for older people, tri- and quadrivalent vaccines to expand protective benefit and
the first approved cell-based vaccine. Data from epidemiological studies are
guiding more effective public health and surveillance strategies to identify and
respond to circulating and novel influenzas.

Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.